Division of Pharmaceutical Sciences, Long Island University, 75 Dekalb Avenue, Brooklyn, NY 11201, United States.
Division of Pharmaceutical Sciences, Long Island University, 75 Dekalb Avenue, Brooklyn, NY 11201, United States; Physical Pharmaceutica LLC, 955 Yonkers Avenue, Suite B10, Yonkers, NY 10704, United States.
Int J Pharm. 2015 Dec 30;496(2):275-81. doi: 10.1016/j.ijpharm.2015.08.064. Epub 2015 Aug 28.
In drug formulations containing polymer excipients, the effects of the polymer on the dissolved free drug concentration and resulting dissolution or release can be important, especially for poorly soluble drugs. In this study, an in vitro method based on pulsatile microdialysis (PMD) was developed to quantitatively determine dissolved free concentrations of drugs in the presence of polymers in aqueous media in situ (e.g., in place within the system being characterized). Formulations were made by dissolving various ratios of the drug griseofulvin and polymer PVP K30 in water and allowing the mix to equilibrate. A PMD probe was immersed in each mixture and the dissolved free drug concentrations were determined in the PMD samples. The experimental procedure and the equations used for data analysis are presented. To assess the consistency of data, a binding model was fit to the data obtained using PMD by calculating the dissolved free drug fraction fD for each drug-polymer ratio in solution, and obtaining the product of the binding stoichiometry and binding constant (νK per mole of polymer) from the slope of a plot of (1-fD)/fD vs. the molar polymer concentration. For comparison, equilibrium binding experiments were also performed at 23C, and the determined value of νK was similar to the value found using PMD. Experiments were performed at three temperatures, and a plot of ln (νK) vs. 1/T was linear and a binding enthalpy of -110.9±4.4J/mol of monomer was calculated from its slope. It was concluded that PMD can be used to determine the dissolved free drug concentrations in situ, which allows characterization of the drug-polymer interaction, even for low drug concentrations. This information may be important in modeling the dissolution or release of drugs from formulations containing polymers.
在含有聚合物辅料的药物制剂中,聚合物对溶解游离药物浓度以及由此产生的溶解或释放的影响可能很重要,尤其是对于水溶性差的药物。在这项研究中,开发了一种基于脉冲微透析(PMD)的体外方法,以定量测定在水介质中存在聚合物时药物的溶解游离浓度原位(例如,在所研究的系统内)。通过将不同比例的药物灰黄霉素和聚合物 PVP K30 溶解在水中并使混合物达到平衡来制备制剂。将 PMD 探头浸入每种混合物中,并在 PMD 样品中测定溶解游离药物浓度。介绍了实验程序和用于数据分析的方程。为了评估数据的一致性,通过 PMD 获得的数据拟合了结合模型,通过计算每种药物-聚合物比在溶液中的溶解游离药物分数 fD,并从(1-fD)/fD 与摩尔聚合物浓度的关系图的斜率获得结合化学计量和结合常数(每摩尔聚合物的 νK)的乘积,从而为每个数据点确定结合化学计量和结合常数(每摩尔聚合物的 νK)。为了进行比较,还在 23°C 下进行了平衡结合实验,并且确定的 νK 值与使用 PMD 找到的值相似。在三种温度下进行了实验,ln(νK)与 1/T 的关系图是线性的,并且从斜率计算出结合焓为-110.9±4.4J/mol 单体。结论是 PMD 可用于原位测定溶解游离药物浓度,从而可以表征药物-聚合物相互作用,即使对于低药物浓度也是如此。这些信息对于模拟含有聚合物的制剂中药物的溶解或释放可能很重要。